Endoglin in HIV-associated preeclamptic placentae

Area of Science:

• Reproductive Biology
• Immunohistochemistry
• Electron Microscopy

Background:

• Preeclampsia is a pregnancy complication with significant maternal and fetal risks.
• Endoglin (Eng) is a protein implicated in vascular function and angiogenesis.
• The role of placental endoglin in preeclampsia, particularly in the context of HIV, requires further investigation.

Purpose of the Study:

• To investigate placental endoglin (Eng) immunoexpression in normotensive and preeclamptic pregnancies.
• To compare Eng expression between HIV-negative and HIV-positive individuals.
• To analyze Eng localization within placental cell populations and subcellular compartments.

Main Methods:

• Immunohistochemistry and immunoelectron microscopy were employed to examine placental tissue.
• Samples were obtained from term pregnancies: normotensive (HIV-negative and HIV-positive) and preeclamptic (HIV-negative and HIV-positive).
• Quantification of Eng immunoexpression in exchange and conducting villi was performed.

Main Results:

• Strong Eng immunoreactivity was detected in endothelial cells, syncytiotrophoblast, cytotrophoblast, and extravillous trophoblast cells.
• Subcellular localization of Eng included the endoplasmic reticulum and mitochondria.
• Significantly higher Eng immunoexpression was observed in both exchange and conducting villi of preeclamptic compared to normotensive groups. HIV status did not significantly affect Eng expression.

Conclusions:

• The immunostaining of endoglin (Eng) in placental cells of HIV-associated preeclamptic placentae is a novel finding.
• Endoglin and its soluble forms represent a dynamic area for placental research in preeclampsia development.
• Increased placental Eng expression is associated with preeclampsia, independent of HIV status.